New Trial Offers PBS Relief for Patients
Image: Epworth HealthCare Chief Medical Officer Luis Prado, Professor of Medicine Miles Prince, Minister for Health Greg Hunt, Executive Director Freemasons and Richmond Nicole Waldron and Group CEO Lachlan Henderson at the recent Pharmaceutical Benefits Scheme (PBS) announcement at Epworth Richmond.
An Australian global clinical trial led by Professor Miles Prince AM has seen a breakthrough drug being added to the Pharmaceutical Benefits Scheme (PBS).
Federal Minister for Health Greg Hunt announced recently at Epworth Richmond that crucial medicines for Cancer, Parkinson's and motor neurone disease will be listed on the scheme as at 1 April 2019.
The Federal Government will invest $19 million to broaden the PBS listing of Adcetris® to include the treatment of a rare cancer called cutaneous T-cell lymphoma, Xadago® listed to treat Parkinson’s disease and Teglutik® for the treatment of motor neurone disease.
Adcetris® as a treatment for skin lymphoma was studied as a part of a large international clinical trial. This study was published in the Lancet, with Professor Prince as lead author.
Professor Miles Prince said that after 6 years hard work, it was astounding that Adcetris® could now be prescribed to patients.
An internationally recognised haematologist, the Director of Molecular Oncology and Cancer Immunology at Epworth HealthCare, Professor Prince has been involved in numerous clinical trials of new therapies for blood cancers and a part of more than 100 clinical trials involving myeloma, lymphoma, leukaemia, transplantation and supportive care.
He has an incredible team of people working on different trials who are the next generation of great innovators in treatment.
As a part of the announcement, the Minister toured the oncology ward at Epworth Richmond to meet with some Epworth patients and was joined by patients and their families in the courtyard afterwards.
Group CEO Lachlan Henderson, Executive Director Freemasons and Richmond Nicole Waldron and Chief Medical Officer Luis Prado, representatives from the pharmaceutical companies as well as Rare Cancer Australia and Lymphoma Australia were also present.
We caught up with Dr Kent Kuswanto, Epworth obstetrician and gynaecologist to talk all things periods.
Recipes brought to you by the Epworth team. You can’t stop at one slice and you’ll never know it’s gluten free! Slice & serve warm.
It’s been a year since we’ve been following sisters Alex and Jane’s bubs - Charlotte and Lola. It’s been a year since they both gave birth to their daughters, one at Epworth Freemasons and the other at Epworth Geelong. Let’s find out how life has changed since then.
An ovarian cyst is a fluid filled sac or pouch which forms on the ovary. Ovarian cysts, in most cases are harmless and resolve on their own. If the cyst is cancerous, it requires medical intervention. Ovarian cysts are common in women of childbearing age.
With 1 in 10 infants now developing a food allergy, being conscious of what you are buying and how you prepare food is more important than ever.